An entrepreneur’s guide to the recreational cannabis market in Europe
Michael Sassano, CEO of Somai Pharmaceuticals reflects on Q3 2022.
Read moreMichael Sassano, CEO of Somai Pharmaceuticals reflects on Q3 2022.
Read moreMichael Sassano, CEO of SOMAÍ Pharmaceuticals Unipessoal LDA, shares his thoughts on recreational cannabis reform in Germany. Leaks of the...
Read moreThe pair say they have a common passion for innovation.
Read moreChris Tasker of Global Cannabinoid Solutions explores cognitive bias, synthetic compounds, the endocannbinoid system and animal testing in cannabis.
Read moreIn the final article of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses red light and...
Read moreIn the second article of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the use of...
Read moreIn the first of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the use of lighting...
Read moreCEO of Brains Bio, Rick Brar, discusses his philosophy that a CEO is only as good as the team they lead.
Read moreIn this article, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the essential elements central to producing a successful...
Read moreIn this article, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the pros and cons of types of germplasm...
Read more© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.